Due to its importance in the regulation of the cardiac action potential, drugs that can interact with hERG are currently being taken out of the market, since this can result in cardiac arrhythmia and sudden death [86, 87]. The gene discussed is KCNH2; the disease is chronic obstructive pulmonary disease.